FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 347:731-736 September 5, 2002 Number 10 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Editorial by Goulder, P. J.R. Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

The detection of an increasing number of circulating recombinant strains of human immunodeficiency virus type 1 (HIV-1) indicates that genetic recombination can occur in cells infected with two strains of HIV-1.^1,2 Coinfection with two circulating strains of HIV-1 has been detected in a few subjects in communities where HIV-1 infection is endemic.³ Coinfection may result from exposure to a second virus either shortly after the initial infection or during the course of established HIV-1 infection; the latter circumstance is called superinfection.

Most viral infections induce lifelong immunity, but reinfection with respiratory viruses such as respiratory syncytial virus is common, most . . . [Full Text of this Article]

Case Report

Methods

Assays

Subtype-Specific Polymerase Chain Reaction

HIV-1 Proviral DNA PCR

Isolation and Growth of Subtypes AE and B in Vitro

Interferon- CD8 Enzyme-Linked Immunospot Assay

Results

Discussion

Source Information

From the Division of Infectious Diseases, University of Geneva, Geneva (S.J., M.-C.B., L.K., S.Y., B.H., L.P.); the Laboratoire d'Immunologie Cellulaire, Hôpital Pitié Salpêtrière, Paris (A.S., B.A.); and Clinical Development Medical Affairs, GlaxoSmithKline, Greenford, United Kingdom (L.-E.G.).

Address reprint requests to Dr. Perrin at the Laboratory of Virology, Geneva University Hospital, 1211 Geneva 14, Switzerland, or at luc.perrin@hcuge.ch.

This article has been cited by other articles:

• Giannecchini, S., Pistello, M., Isola, P., Matteucci, D., Mazzetti, P., Freer, G., Bendinelli, M. (2007). Role of Env in Resistance of Feline Immunodeficiency Virus (FIV)-Infected Cats to Superinfection by a Second FIV Strain as Determined by Using a Chimeric Virus. J. Virol. 81: 10474-10485 [Abstract] [Full Text]  
• Deeks, S. G., Schweighardt, B., Wrin, T., Galovich, J., Hoh, R., Sinclair, E., Hunt, P., McCune, J. M., Martin, J. N., Petropoulos, C. J., Hecht, F. M. (2006). Neutralizing Antibody Responses against Autologous and Heterologous Viruses in Acute versus Chronic Human Immunodeficiency Virus (HIV) Infection: Evidence for a Constraint on the Ability of HIV To Completely Evade Neutralizing Antibody Responses.. J. Virol. 80: 6155-6164 [Abstract] [Full Text]  
• Bergmeier, L.A., Lehner, T. (2006). Innate and Adaptive Mucosal Immunity in Protection against HIV Infection. Adv. Dent. Res. 19: 21-28 [Abstract] [Full Text]  
• Galetto, R., Giacomoni, V., Veron, M., Negroni, M. (2006). Dissection of a Circumscribed Recombination Hot Spot in HIV-1 after a Single Infectious Cycle. J. Biol. Chem. 281: 2711-2720 [Abstract] [Full Text]  
• McCutchan, F. E., Hoelscher, M., Tovanabutra, S., Piyasirisilp, S., Sanders-Buell, E., Ramos, G., Jagodzinski, L., Polonis, V., Maboko, L., Mmbando, D., Hoffmann, O., Riedner, G., von Sonnenburg, F., Robb, M., Birx, D. L. (2005). In-Depth Analysis of a Heterosexually Acquired Human Immunodeficiency Virus Type 1 Superinfection: Evolution, Temporal Fluctuation, and Intercompartment Dynamics from the Seronegative Window Period through 30 Months Postinfection. J. Virol. 79: 11693-11704 [Abstract] [Full Text]  
• Chohan, B., Lavreys, L., Rainwater, S. M. J., Overbaugh, J. (2005). Evidence for Frequent Reinfection with Human Immunodeficiency Virus Type 1 of a Different Subtype. J. Virol. 79: 10701-10708 [Abstract] [Full Text]  
• Strain, M. C., Letendre, S., Pillai, S. K., Russell, T., Ignacio, C. C., Gunthard, H. F., Good, B., Smith, D. M., Wolinsky, S. M., Furtado, M., Marquie-Beck, J., Durelle, J., Grant, I., Richman, D. D., Marcotte, T., McCutchan, J. A., Ellis, R. J., Wong, J. K. (2005). Genetic Composition of Human Immunodeficiency Virus Type 1 in Cerebrospinal Fluid and Blood without Treatment and during Failing Antiretroviral Therapy. J. Virol. 79: 1772-1788 [Abstract] [Full Text]  
• van Kesteren, N. M. C., Hospers, H. J., Kok, G., van Empelen, P. (2005). Sexuality and Sexual Risk Behavior in HIV-Positive Men Who Have Sex With Men. Qual Health Res 15: 145-168 [Abstract]  
• Yang, O. O., Daar, E. S., Jamieson, B. D., Balamurugan, A., Smith, D. M., Pitt, J. A., Petropoulos, C. J., Richman, D. D., Little, S. J., Brown, A. J. L. (2005). Human Immunodeficiency Virus Type 1 Clade B Superinfection: Evidence for Differential Immune Containment of Distinct Clade B Strains. J. Virol. 79: 860-868 [Abstract] [Full Text]  
• Martinez-Picado, J., Morales-Lopetegi, K., Villena, C., Gutierrez, C., Izquierdo, N., Marfil, S., Clotet, B., Ruiz, L. (2005). Evidence for Preferential Genotyping of a Minority Human Immunodeficiency Virus Population Due to Primer-Template Mismatching during PCR-Based Amplification. J. Clin. Microbiol. 43: 436-438 [Abstract] [Full Text]  
• Haaft, P. t., Verschoor, E. J., Verstrepen, B., Niphuis, H., Dubbes, R., Koornstra, W., Bogers, W., Rosenwirth, B., Heeney, J. L. (2004). Readily acquired secondary infections of human and simian immunodeficiency viruses following single intravenous exposure in non-human primates. J. Gen. Virol. 85: 3735-3745 [Abstract] [Full Text]  
• Furutsuki, T., Hosoya, N., Kawana-Tachikawa, A., Tomizawa, M., Odawara, T., Goto, M., Kitamura, Y., Nakamura, T., Kelleher, A. D., Cooper, D. A., Iwamoto, A. (2004). Frequent Transmission of Cytotoxic-T-Lymphocyte Escape Mutants of Human Immunodeficiency Virus Type 1 in the Highly HLA-A24-Positive Japanese Population. J. Virol. 78: 8437-8445 [Abstract] [Full Text]  
• Reggeti, F., Bienzle, D. (2004). Feline immunodeficiency virus subtypes A, B and C and intersubtype recombinants in Ontario, Canada. J. Gen. Virol. 85: 1843-1852 [Abstract] [Full Text]  
• Wherry, E. J., Ahmed, R. (2004). Memory CD8 T-Cell Differentiation during Viral Infection. J. Virol. 78: 5535-5545 [Full Text]  
• Tsui, R., Herring, B. L., Barbour, J. D., Grant, R. M., Bacchetti, P., Kral, A., Edlin, B. R., Delwart, E. L. (2004). Human Immunodeficiency Virus Type 1 Superinfection Was Not Detected following 215 Years of Injection Drug User Exposure. J. Virol. 78: 94-103 [Abstract] [Full Text]  
• Pistello, M., Matteucci, D., Bonci, F., Isola, P., Mazzetti, P., Zaccaro, L., Merico, A., Del Mauro, D., Flynn, N., Bendinelli, M. (2003). AIDS Vaccination Studies Using an Ex Vivo Feline Immunodeficiency Virus Model: Protection from an Intraclade Challenge Administered Systemically or Mucosally by an Attenuated Vaccine. J. Virol. 77: 10740-10750 [Abstract] [Full Text]  
• Roland, M. E., Lo, B., Braff, J., Stock, P. G. (2003). Key Clinical, Ethical, and Policy Issues in the Evaluation of the Safety and Effectiveness of Solid Organ Transplantation in HIV-Infected Patients. Arch Intern Med 163: 1773-1778 [Full Text]  
• Youle, M., Wainberg, M. A. (2003). Pre-Exposure Chemoprophylaxis (PREP) as an HIV Prevention Strategy. J Int Assoc Physicians AIDS Care (Chic Ill) 2: 102-105 [Abstract]  
• (2003). Therapeutic Vaccination: Where Are We Now?. AIDS Clin Care 2003: 1-1 [Full Text]  
• (2002). HIV Superinfection. AIDS Clin Care 2002: 9-9 [Full Text]  
• (2002). A Case Worth Noting: HIV Superinfection. JWatch Infect. Diseases 2002: 1-1 [Full Text]  
• Gottlieb, S. (2002). Patient is reinfected with a different HIV strain. BMJ 325: 564-564 [Full Text]  
• Goulder, P. J.R., Walker, B. D. (2002). HIV-1 Superinfection -- A Word of Caution. NEJM 347: 756-758 [Full Text]